Close Menu

NEW YORK (360Dx) – Lucid Diagnostics said today that it has submitted a 510(k) application to the US Food and Drug Administration for the EsoCheck Cell Collection Device, which detects Barrett's Esophagus (BE) in patients at risk of esophageal cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.